Latest Schedule 13G passive stakes

JPMorgan Chase & Co. has filed a Schedule 13G, reporting a beneficial ownership of 9.8% in Burlington Stores, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has updated its Schedule 13G filing, reporting beneficial ownership of 6.9% of Baker Hughes Company's Class A Common Stock as of June 30, 2026.

JPMorgan Chase & Co. has updated its Schedule 13G filing, reporting beneficial ownership of 6.9% of Baker Hughes Company's Class A Common Stock as of June 30, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 7.5% of AutoZone, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 7.5% of AutoZone, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Arthur J. Gallagher & Co. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Arthur J. Gallagher & Co. common stock as of June 30, 2026.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.15% of LeMaitre Vascular, Inc. common stock.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 10.4% of Andersen Group Inc.'s Class A common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 10.4% of Andersen Group Inc.'s Class A common stock as of June 30, 2026.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation jointly report a 5.32% stake in Winmark Corporation as of June 30, 2026.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.17% of Snap-on Incorporated's common stock as of June 30, 2026.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.27% of Nuveen Select Tax-Free Income Portfolio's common stock.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.31% in Nuveen New York AMT-Free Quality Municipal Income Fund.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.09% of National HealthCare Corporation's common stock.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.00% of Nuveen Real Asset Income and Growth Fund's common stock.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 18,171,886 shares of F.N.B. Corporation common stock, representing 5.10% of the class.

A Schedule 13G filing reveals Orin Hirschman and AIGH Capital Management LLC's beneficial ownership of Coya Therapeutics, Inc. common stock.

A Schedule 13G filing reveals that Orin Hirschman and AIGH Capital Management LLC hold 0% of Intellicheck, Inc. common stock as of June 30, 2026.

AIGH Capital Management and related entities report beneficial ownership of 4.9% of SmartKem, Inc. common stock, primarily through exercisable warrants.

Aberdeen Group plc and abrdn Inc. have jointly reported beneficial ownership of 9.91% of Eloxx Pharmaceuticals Inc. common stock as of June 30, 2026.

TCG Crossover entities and Chen Yu have updated their Schedule 13G filing, reporting a combined beneficial ownership of 9.9% in Surrozen, Inc.

Vladimir Galkin, Angelica Galkin, and the Angelica Galkin Revocable Trust have jointly filed a Schedule 13G, reporting beneficial ownership of 5% of One Stop Systems, Inc. common stock.

George Shapiro, M.D. has filed an amended Schedule 13G, reporting beneficial ownership of 1,311,271 shares, representing 15.1% of Zeo Scientifix, Inc.'s common stock.

Cleveland Capital Management and affiliated entities report a combined 10.1% stake in Virco Mfg. Corp., with Wade Massad holding the largest individual beneficial ownership.

Divisadero Street Capital Management, LP and affiliated entities report beneficial ownership of 6.9% of Beta Bionics, Inc. common stock.

Cleveland Capital Management and associated entities report an increased beneficial ownership stake in Flux Power Holdings, Inc. to 7.1%.

John M. Pasquesi and Otter Capital LLC report beneficial ownership of 19.99% of ClearSign Technologies Corp. common stock.

Eli Lilly and Company has reported a significant beneficial ownership stake of 15.6% in ProQR Therapeutics N.V., holding 21,995,880 ordinary shares.

Eli Lilly and Company has reported a significant beneficial ownership stake of 15.6% in ProQR Therapeutics N.V., holding 21,995,880 ordinary shares.